Journal article
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
Journal of the American Medical Informatics Association : JAMIA, Vol.28(3), pp.427-443
03/01/2021
DOI: 10.1093/jamia/ocaa196
PMID: 32805036
Abstract
Abstract Objective Coronavirus disease 2019 (COVID-19) poses societal challenges that require expeditious data and knowledge sharing. Though organizational clinical data are abundant, these are largely inaccessible to outside researchers. Statistical, machine learning, and causal analyses are most successful with large-scale data beyond what is available in any given organization. Here, we introduce the National COVID Cohort Collaborative (N3C), an open science community focused on analyzing patient-level data from many centers. Materials and Methods The Clinical and Translational Science Award Program and scientific community created N3C to overcome technical, regulatory, policy, and governance barriers to sharing and harmonizing individual-level clinical data. We developed solutions to extract, aggregate, and harmonize data across organizations and data models, and created a secure data enclave to enable efficient, transparent, and reproducible collaborative analytics. Results Organized in inclusive workstreams, we created legal agreements and governance for organizations and researchers; data extraction scripts to identify and ingest positive, negative, and possible COVID-19 cases; a data quality assurance and harmonization pipeline to create a single harmonized dataset; population of the secure data enclave with data, machine learning, and statistical analytics tools; dissemination mechanisms; and a synthetic data pilot to democratize data access. Conclusions The N3C has demonstrated that a multisite collaborative learning health network can overcome barriers to rapidly build a scalable infrastructure incorporating multiorganizational clinical data for COVID-19 analytics. We expect this effort to save lives by enabling rapid collaboration among clinicians, researchers, and data scientists to identify treatments and specialized care and thereby reduce the immediate and long-term impacts of COVID-19.
Details
- Title: Subtitle
- The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment
- Creators
- Melissa A Haendel - Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon, USA, Translational and Integrative Sciences Center, Department of Molecular Toxicology, Oregon State University, Corvallis, Oregon, USAChristopher G Chute - Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, Maryland, USATellen D Bennett - Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado, USADavid A Eichmann - School of Library and Information Science, The University of Iowa, Iowa City, Iowa, USAJustin Guinney - Sage Bionetworks, Seattle, Washington, USAWarren A Kibbe - Duke University, Durham,North Carolina, USAPhilip R O Payne - Institute for Informatics, Washington University in St. Louis, Saint Louis,Missouri, USAEmily R Pfaff - North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAPeter N Robinson - Jackson Laboratory, Bar Harbor, Maine, USAJoel H Saltz - Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USAHeidi Spratt - University of Texas Medical Branch, Galveston, Texas, USAChristine Suver - Sage Bionetworks, Seattle, Washington, USAJohn Wilbanks - Sage Bionetworks, Seattle, Washington, USAAdam B Wilcox - University of Washington, Seattle, Washington, USAAndrew E Williams - Virginia Commonwealth UniversityChunlei Wu - Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USAClair Blacketer - Janssen Research and Development, LLC, Raritan, New Jersey, USARobert L Bradford - North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAJames J Cimino - University of Alabama-Birmingham, Birmingham, Alabama, USAMarshall Clark - North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAEvan W Colmenares - Department of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAPatricia A Francis - Johns Hopkins University School of Medicine, Baltimore, Maryland, USADavera Gabriel - Johns Hopkins University School of Medicine, Baltimore, Maryland, USAAlexis Graves - University of Iowa Institute for Clinical and Translational Science, The University of Iowa, Iowa City, Iowa, USARaju Hemadri - National Center for Advancing Translational Science, Bethesda, Maryland, USAStephanie S Hong - Johns Hopkins University School of Medicine, Baltimore, Maryland, USAGeorge Hripscak - Department of Biomedical Informatics, Columbia University, New York, New York, USADazhi Jiao - Johns Hopkins University School of Medicine, Baltimore, Maryland, USAJeffrey G Klann - Harvard Medical School, Boston,Massachusetts, USAKristin Kostka - IQVIA, Durham, North Carolina, USAAdam M Lee - University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAHarold P Lehmann - Johns Hopkins University School of Medicine, Baltimore, Maryland, USALora Lingrey - TriNetX, Cambridge,Massachusetts, USARobert T Miller - Tufts Clinical and Translational Science Institute, Tufts University, Boston,Massachusetts, USAMichele Morris - Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh,Pennsylvania, USAShawn N Murphy - Mass General Brigham, Boston,Massachusetts, USAKarthik Natarajan - Irving Medical Center, Columbia University, New York, New York, USAMatvey B Palchuk - TriNetX, Cambridge,Massachusetts, USAUsman Sheikh - National Center for Advancing Translational Science, Bethesda, Maryland, USAHarold Solbrig - Johns Hopkins University School of Medicine, Baltimore, Maryland, USAShyam Visweswaran - Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh,Pennsylvania, USAAnita Walden - Oregon Clinical and Translational Research Institute, Oregon Health and Science University, Portland, Oregon, USA, Sage Bionetworks, Seattle, Washington, USAKellie M Walters - North Carolina Translational and Clinical Sciences Institute (NC TraCS), University of North Carolina at Chapel Hill, Chapel Hill,North Carolina, USAGriffin M Weber - Department of Biomedical Informatics, Harvard Medical School, Boston,Massachusetts, USAXiaohan Tanner Zhang - Johns Hopkins University School of Medicine, Baltimore, Maryland, USARichard L Zhu - Johns Hopkins University School of Medicine, Baltimore, Maryland, USABenjamin Amor - Palantir Technologies, Palo Alto, California, USAAndrew T Girvin - Palantir Technologies, Palo Alto, California, USAAmin Manna - Palantir Technologies, Palo Alto, California, USANabeel Qureshi - Palantir Technologies, Palo Alto, California, USAMichael G Kurilla - Division of Clinical Innovation, National Center for Advancing Translational Science, Bethesda, Maryland, USASam G Michael - National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USALili M Portilla - Office of Strategic Alliances, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USAJoni L Rutter - Office of the Director, National Center for Advancing Translational Science, Bethesda, Maryland, USAChristopher P Austin - National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland, USAKen R Gersing - National Center for Advancing Translational Science, Bethesda, Maryland, USANational COVID Cohort Collaborative (N3C)
- Resource Type
- Journal article
- Publication Details
- Journal of the American Medical Informatics Association : JAMIA, Vol.28(3), pp.427-443
- DOI
- 10.1093/jamia/ocaa196
- PMID
- 32805036
- NLM abbreviation
- J Am Med Inform Assoc
- ISSN
- 1527-974X
- eISSN
- 1527-974X
- Grant note
- DOI: 10.13039/100000002, name: National Institutes of Health; name: National Center for Advancing Translational Sciences Institute, award: U24TR002306
- Language
- English
- Date published
- 03/01/2021
- Academic Unit
- School of Library and Information Science
- Record Identifier
- 9984080111802771
Metrics
68 Record Views